{
"NDC": {
"NDCCode": "63020-210-21",
"PackageDescription": "1 BOTTLE in 1 CARTON (63020-210-21) / 21 CAPSULE in 1 BOTTLE",
"NDC11Code": "63020-0210-21",
"ProductNDC": "63020-210",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Fruzaqla",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Fruquintinib",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20231108",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA217564",
"LabelerName": "Takeda Pharmaceuticals America, Inc.",
"SubstanceName": "FRUQUINTINIB",
"StrengthNumber": "1",
"StrengthUnit": "mg/1",
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-03-10",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20231108",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}